These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Fluvastatin for lowering cholesterol. Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137 [No Abstract] [Full Text] [Related]
32. Rhabdomyolysis secondary to hyponatraemia. Lara Aguayo P; de la Fuente Martos C; Morán Fernández E; Soriano Rodríguez F; Rojas Amezcua M; Aguilar Alonso E Nefrologia; 2011; 31(4):500-2. PubMed ID: 21738260 [No Abstract] [Full Text] [Related]
33. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462 [TBL] [Abstract][Full Text] [Related]
34. Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report. Meyer zu Schwabedissen HE; Siegmund W; Kroemer HK; Rollnik JD BMC Res Notes; 2014 Oct; 7():688. PubMed ID: 25280537 [TBL] [Abstract][Full Text] [Related]
35. Fluvastatin: a review of its use in lipid disorders. Langtry HD; Markham A Drugs; 1999 Apr; 57(4):583-606. PubMed ID: 10235694 [TBL] [Abstract][Full Text] [Related]
36. Fluvastatin treatment is not associated with an increased incidence of cancer. Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542 [TBL] [Abstract][Full Text] [Related]
37. Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. Pierno S; Didonna MP; Cippone V; De Luca A; Pisoni M; Frigeri A; Nicchia GP; Svelto M; Chiesa G; Sirtori C; Scanziani E; Rizzo C; De Vito D; Conte Camerino D Br J Pharmacol; 2006 Dec; 149(7):909-19. PubMed ID: 17031388 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study]. Zhao S; Wang F; Yang K; Hao Y; Li G; Yang M; Yang Z Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):455-9. PubMed ID: 25146513 [TBL] [Abstract][Full Text] [Related]
40. [Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase]. Fuentes I; Aguilera C Med Clin (Barc); 1998 Nov; 111(18):700. PubMed ID: 9887435 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]